Core Laboratories (CLB) Misses Q3 EPS by 4c, Guidance Comes in Light

October 19, 2016 4:22 PM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.35, $0.04 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $146.23 million.


Core Laboratories sees Q4 2016 EPS of $0.38-$0.40, versus the consensus of $0.41. Core Laboratories sees Q4 2016 revenue of $143-145 million, versus the consensus of $148.2 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment